Related Experiment Videos
The San Daniele 2 Project: protocol description and population characteristics
Patrizio Prati1, Diego Vanuzzo, Marco Casaroli
1Neurology Department, Gervasutta Hospital, Udine. patrizio.prati@libero.it
Summary
This study tracked carotid atherosclerosis in an Italian population, finding significant links to age, blood pressure, and smoking. Follow-up research will examine risk factors and cardiovascular events in survivors.
Area of Science:
- Cardiovascular Epidemiology
- Vascular Biology
- Preventive Cardiology
Background:
- The San Daniele Project initially assessed carotid atherosclerosis prevalence and risk factors in an Italian population in 1990.
- Subclinical carotid atherosclerosis was prevalent (25.4% men, 26.4% women) and associated with age, systolic blood pressure, smoking, and HDL cholesterol.
Purpose of the Study:
- To prospectively evaluate changes in carotid atherosclerosis findings over time.
- To investigate the relationship between carotid findings, cardiovascular risk factors, and incident cardiovascular events.
- To explore genetic polymorphisms, and atrial fibrillation incidence and determinants in the cohort.
Main Methods:
- Cross-sectional analysis of 1990 data using intima-media thickness and plaque presence/stenosis.
- Longitudinal re-examination of the cohort in 2002 to track atherosclerosis progression.
- Comparison of cohort characteristics with the general regional population to enhance generalizability.
Main Results:
- In 1990, age, systolic blood pressure, and smoking were significant risk factors for carotid plaques/stenosis.
- High-density lipoprotein cholesterol showed a protective effect.
- Prevalence rates were similar between men and women in the initial study.
Conclusions:
- Carotid atherosclerosis is common in the general population and linked to modifiable risk factors.
- The San Daniele Project provides a valuable longitudinal dataset for studying cardiovascular disease progression and prediction.
- Future research will leverage genetic data and atrial fibrillation incidence to further understand atherosclerosis determinants.